Abstract
In the past two decades, the production levels for monoclonal antibodies in mammalian expression systems have improved dramatically. Single cell productivity for monoclonal antibodies has increased 20–50 fold due to the improvements in expression hosts, expression vectors, cell culture media, and production processes. However, most of these improvements are proprietary to large pharmaceutical/biotech companies and involve large steel-tank bioreactors. Therefore, these processes are difficult for small companies and academic labs to reproduce. Transient expression in mammalian cells has recently been used very widely for monoclonal antibody expression. Cell line and expression vector engineering increased expression levels to several hundred milligrams per liter. The availability of highly effective transfection reagents and disposable bioreactors make the transient expression process an efficient and cost-effective way to make recombinant antibodies in large quantity. Here, we describe the protocols for small- to mid-scale transient expression of monoclonal antibodies in shake-flasks and for large-scale production in WAVE bioreactors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beck A, Wurch T, Reichert JM (2011) 6th Annual European Antibody Congress 2010: November 29–December 1, 2010, Geneva, Switzerland. MAbs 3:111–132
Nelson AL, Dhimolea E, Reichert JM (2010) Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 9:767–774
Durocher Y, Butler M (2009) Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol 20:700–707
Jones Susan Dana, Castillo Francisco J, Levine Howard L (2007) Advances in the development of therapeutic monoclonal antibodies. BioPharm Int 96–114
Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393–1398
Havenga MJ, Holterman L, Melis I, Smits S, Kaspers J, Heemskerk E, van der Vlugt R, Koldijk M, Schouten GJ, Hateboer G et al (2008) Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity. Biotechnol Bioeng 100:273–283
Barnes LM, Bentley CM, Dickson AJ (2000) Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 32:109–123
Bebbington CR, Renner G, Thomson S, King D, Abrams D, Yarranton GT (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (NY) 10:169–175
Kaufman RJ, Schimke RT (1981) Amplification and loss of dihydrofolate reductase genes in a Chinese hamster ovary cell line. Mol Cell Biol 1:1069–1076
Urlaub G, Kas E, Carothers AM, Chasin LA (1983) Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 33:405–412
Kaufman RJ, Sharp PA (1982) Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene. J Mol Biol 159:601–621
Ringold G, Dieckmann B, Lee F (1981) Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells. J Mol Appl Genet 1:165–175
Cockett MI, Bebbington CR, Yarranton GT (1990) High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification. Biotechnology (NY) 8:662–667
de la Cruz Edmonds MC, Tellers M, Chan C, Salmon P, Robinson DK, Markusen J (2006) Development of transfection and high-producer screening protocols for the CHOK1SV cell system. Mol Biotechnol 34:179–190
Ye J, Alvin K, Latif H, Hsu A, Parikh V, Whitmer T, Tellers M, de la Cruz Edmonds MC, Ly J, Salmon P et al (2010) Rapid protein production using CHO stable transfection pools. Biotechnol Prog 26:1431–1437
Andersen DC, Reilly DE (2004) Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol 15:456–462
Benton T, Chen T, McEntee M, Fox B, King D, Crombie R, Thomas TC, Bebbington C (2002) The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology 38:43–46
Bianchi AA, McGrew JT (2003) High-level expression of full-length antibodies using trans-complementing expression vectors. Biotechnol Bioeng 84:439–444
Kwaks TH, Barnett P, Hemrika W, Siersma T, Sewalt RG, Satijn DP, Brons JF, van Blokland R, Kwakman P, Kruckeberg AL et al (2003) Identification of anti-repressor elements that confer high and stable protein production in mammalian cells. Nat Biotechnol 21:553–558
Zahn-Zabal M, Kobr M, Girod PA, Imhof M, Chatellard P, De JM, Wurm F, Mermod N (2001) Development of stable cell lines for production or regulated expression using matrix attachment regions. J Biotechnol 87:29–42
Hacker DL, De JM, Wurm FM (2009) 25 Years of recombinant proteins from reactor-grown cells—where do we go from here? Biotechnol Adv 27:1023–1027
Baldi L, Hacker DL, Adam M, Wurm FM (2007) Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett 29:677–684
Girard P, Derouazi M, Baumgartner G, Bourgeois M, Jordan M, Jacko B, Wurm FM (2002) 100-Liter transient transfection. Cytotechnology 38:15–21
Pham PL, Kamen A, Durocher Y (2006) Large-scale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol 34:225–237
Durocher Y, Perret S, Kamen A (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30:E9
Meissner P, Pick H, Kulangara A, Chatellard P, Friedrich K, Wurm FM (2001) Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng 75:197–203
Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De JM, Wurm FM (2008) Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res 36:e96
Zhang J, Liu X, Bell A, To R, Baral TN, Azizi A, Li J, Cass B, Durocher Y (2009) Transient expression and purification of chimeric heavy chain antibodies. Protein Exp Purif 65:77–82
Backliwal G, Hildinger M, Chenuet S, Dejesus M, Wurm FM (2008) Coexpression of acidic fibroblast growth factor enhances specific productivity and antibody titers in transiently transfected HEK293 cells. Nat Biotechnol 25:162–166
Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM (2008) Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng 101:182–189
Rajendra Y, Kiseljak D, Baldi L, Hacker DL, Wurm FM (2011) A simple high-yielding process for transient gene expression in CHO cells. J Biotechnol 153:22–26
Ye J, Kober V, Tellers M, Naji Z, Salmon P, Markusen JF (2009) High-level protein expression in scalable CHO transient transfection. Biotechnol Bioeng 103:542–551
Codamo J, Munro TP, Hughes BS, Song M, Gray PP (2011) Enhanced CHO cell-based transient gene expression with the epi-CHO expression system. Mol Biotechnol 48:109–115
Silla T, Haal I, Geimanen J, Janikson K, Abroi A, Ustav E, Ustav M (2005) Episomal maintenance of plasmids with hybrid origins in mouse cells. J Virol 79:15277–15288
Product information and use protocols for FuGENE HD and X-tremeGENE HP DNA transfection reagents. www.roche-applied-science.com. 2011
Singh V (1999) Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology 30:149–158
Werner S, Eibl R, Lettenbauer C, Roll M, Eibl D, De JM, Zhang X, Stettler M, Tissot S, Burki C et al (2010) Innovative, non-stirred bioreactors in scales from milliliters up to 1000 liters for suspension cultures of cells using disposable bags and containers—a Swiss contribution. Chimia (Aarau) 64:819–823
Zhang X, Stettler M, De SD, Perrone M, Parolini N, Discacciati M, De JM, Hacker D, Quarteroni A, Wurm F (2010) Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1,000-liter scale. Adv Biochem Eng Biotechnol 115:33–53
Kalmbach A, Bordas R, Oncul AA, Thevenin D, Genzel Y, Reichl U (2011) Experimental characterization of flow conditions in 2- and 20-L bioreactors with wave-induced motion. Biotechnol Prog 27:402–409
Raymond C, Tom R, Perret S, Moussouami P, L’abbe D, St-Laurent G, Durocher Y (2011) A simplified polyethylenimine-mediated transfection process for large-scale and high-throughput applications. Methods 55(1):44–51
Hami LS, Green C, Leshinsky N, Markham E, Miller K, Craig S (2004) GMP production and testing of Xcellerated T cells for the treatment of patients with CLL. Cytotherapy 6:554–562
Franek F, Hohenwarter O, Katinger H (2000) Plant protein hydrolysates: preparation of defined peptide fractions promoting growth and production in animal cells cultures. Biotechnol Prog 16:688–692
Franek F, Eckschlager T, Katinger H (2003) Enhancement of monoclonal antibody production by lysine-containing peptides. Biotechnol Prog 19:169–174
Wulhfard S, Baldi L, Hacker DL, Wurm F (2010) Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells. J Biotechnol 148:128–132
Wulhfard S, Tissot S, Bouchet S, Cevey J, De JM, Hacker DL, Wurm FM (2008) Mild hypothermia improves transient gene expression yields several fold in Chinese hamster ovary cells. Biotechnol Prog 24:458–465
WAVE Bioreactor Literature. www.gelifesciences.com/aptrix/upp01077.nsf/Content/wave_bioreactor_home∼wave_literature. 2011
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Zhang, R.Y., Shen, W.D. (2012). Monoclonal Antibody Expression in Mammalian Cells. In: Chames, P. (eds) Antibody Engineering. Methods in Molecular Biology, vol 907. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-974-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-61779-974-7_20
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-973-0
Online ISBN: 978-1-61779-974-7
eBook Packages: Springer Protocols